General Information
Revision date
2018-12-06
Product name
Tetrabenazine Tablets
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Tetrabenazine is contraindicated in patients: Who are actively suicidal, or in patients with untreated or inadequately treated depression With hepatic impairment Taking monoamine oxidase inhibitors (MAOIs). Tetrabenazine should not be used in combination with an MAOI, or within a minimum of 14 days of discontinuing therapy with an MAOI Taking reserpine. At least 20 days should elapse after stopping reserpine before starting tetrabenazine Taking deutetrabenazine or valbenazine
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
